The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health
<p>Abstract</p> <p>Background</p> <p>Metabolic Syndrome, or Syndrome X, is characterized by a set of metabolic and lipid imbalances that greatly increases the risk of developing diabetes and cardiovascular disease. The syndrome is highly prevalent in the United States a...
Main Authors: | Hildreth DeWall J, Thomas Tiffany C, Mbanya Dora, Kuate Dieudonne, Enonchong Ebangha, Oben Julius, Ingolia Thomas D, Tempesta Michael S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-09-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/6/1/20 |
Similar Items
-
ProAlgaZyme and its subfractions increase plasma HDL cholesterol via upregulation of ApoA1, ABCA1, and SRB1, and inhibition of CETP in hypercholesterolemic hamsters
by: Geamanu A, et al.
Published: (2012-06-01) -
Algae Biorefinery – Material and energy use of algae
by: Petrick, Ingolf, et al.
Published: (2014) -
<it>Phellodendron </it>and <it>Citrus </it>extracts benefit joint health in osteoarthritis patients: a pilot, double-blind, placebo-controlled study
by: Chambliss Walter, et al.
Published: (2009-08-01) -
<it>Phellodendron </it>and <it>Citrus </it>extracts benefit cardiovascular health in osteoarthritis patients: a double-blind, placebo-controlled pilot study
by: Chambliss Walter, et al.
Published: (2008-05-01) -
Zyme: Building a speciality IT services firm
by: D.V.R. Seshadri
Published: (2010-03-01)